Global Sample Preparation in Genomics, Proteomics and Epigenomics Market size is expected to reach US$ 10.09 Bn. by year 2029 at a CAGR of 5.3% during the forecast period. Sample preparation in genomics, proteomics and epigenomics have the wide applications in biotechnology to increase the research and development activities.To Know About The Research Methodology :- Request Free Sample Report The report covers the current estimate and forecast for sample preparation in genomics, proteomics and epigenomics market on a global and a regional level. The report provides an in-depth analysis of the sample preparation in genomics, proteomics and epigenomics market for the period 2023 – 2029, wherein 2022 is the base year and the period from 2023 to 2029 is the forecast period. Data for 2018- 2022 has been included as historical information. The study provides a detailed perspective on market growth, throughout the above forecast period in terms of revenue estimates (in US$ MN), across different geographies, which includes North America (NA), Europe (EU), Asia Pacific (APAC), Middle East & Africa (MEA) and Latin America (LATAM). The report provides qualitative and quantitative insights on the Sample preparation in genomics, proteomics and epigenomics industry trends and detail analysis of market size and growth rate of all segment in the market. This report highlights the main segments in the sample preparation in genomics, proteomics, and epigenomics industry: Application, End User and Region.
Global Sample Preparation in Genomics, Proteomics and Epigenomics Market Dynamics
The increasing research and development activities in biology and molecular modelling use the genomics, proteomics samples as a basic building blocks. Basic research carried out in wet laboratories use the samples, which will help in further research. The growing applications of gene and protein studies able to show the detail insights for new drug discovery and pharmacokinetic/pharmacodynamics properties. Forensic laboratories analyze the epigenomics samples to find out the criminal in fraud cases. Genomics application commended the largest market share of xx% by 2029. Genetic sample holds the information regarding the genetic sequence of individual. Genetic sample have the wide applications in analysis of DNA sequence, with detail study of nucleotide polymorphism, genetic sequenced tags, and detail study of genes associated with hereditary disorders. Comparative study of genomics and gene sequences help researchers to reach on better conclusion. The growing industry of data mining use the laboratory results of genomic samples to find out the basic aspects of genomic annotation and gene modelling. Biotechnology is playing a key role in evolution of industry by studying the samples with human genes, proteins, and DNA content. Biotechnology have touched the every corner of sample preparation for genomic, proteomic, epigenomic and that is the first step which will further give insights about molecular modelling, also give basic insights to bio –informaticians for further computational analysis. Sample content with genomics, proteomics & epigenomics used by biotechnologist and researchers to make further research in the fields of biopharmaceuticals, vaccines, antibodies and biotherapeutics. Department of biotechnology covers the study, specific to genomics, proteomics and Epigenomics. The biotechnology industry is mainly focused on the research with genomics, proteomics and epigenomics to find out gene-disease interactions, hereditary diseases, mostly in identification of drug targets. North America is increasing their strength in chemical, biological and environmental sciences. Availability of research community to provide the foundation, understanding and breakthrough to achieve large scale opportunities drive the global sample preparation in genomics, proteomics and epigenomics market. The market is expected to witness a growth rate of over 20 percent in the biotechnology sector and presents lucrative investment opportunities for global market. United States rank first in the number of biotech firms and biomedical research activities hence the global market has the opportunities to grow in the forecast period. Continuous spending on R & D, availability of venture capital and support, favourable settings to operate and grow biotechnology.Scope of the Global Sample Preparation in Genomics, Proteomics and Epigenomics Market: Inquire before buying
Global Sample Preparation in Genomics, Proteomics and Epigenomics Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 7.03 Bn. Forecast Period 2023 to 2029 CAGR: 5.3% Market Size in 2029: US $ 10.09 Bn. Segments Covered: by Application Genomics Proteomics Epigenomics Other Application by End User Pharmaceutical Biotechnology Molecular Diagnostics Others End User Global Sample Preparation in Genomics, Proteomics and Epigenomics Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Global Sample Preparation in Genomics, Proteomics and Epigenomics Market, Key Players are
1. Agilent Technologies 2. Bio-Rad Laboratories 3. Biotage AB 4. Danaher Corporation 5. F Hoffman La Roche 6. Illumina Inc. 7. Merck KgaA 8. PerkinElmer Inc. 9. Qiagen N.V. 10. Thermo Fisher Scientific Inc. 11. Waters Corporation Frequently Asked Questions: 1. Which region has the largest share in Global Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Market? Ans: The Global Sample Preparation in Genomics, Proteomics and Epigenomics Market is growing at a CAGR of 5.3% during forecasting period 2023-2029. 3. What is scope of the Global Market report? Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Market? Ans: The important key players in the Global Market are – Agilent Technologies, Bio-Rad Laboratories, Biotage AB, Danaher Corporation, F Hoffman La Roche, Illumina Inc., Merck KgaA, PerkinElmer Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Waters Corporation. 5. What is the study period of this Market? Ans: The Global Market is studied from 2022 to 2029.
1. Sample Preparation in Genomics, Proteomics and Epigenomics Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Sample Preparation in Genomics, Proteomics and Epigenomics Market: Dynamics 2.1. Sample Preparation in Genomics, Proteomics and Epigenomics Market Trends by Region 2.1.1. North America Sample Preparation in Genomics, Proteomics and Epigenomics Market Trends 2.1.2. Europe Sample Preparation in Genomics, Proteomics and Epigenomics Market Trends 2.1.3. Asia Pacific Sample Preparation in Genomics, Proteomics and Epigenomics Market Trends 2.1.4. Middle East and Africa Sample Preparation in Genomics, Proteomics and Epigenomics Market Trends 2.1.5. South America Sample Preparation in Genomics, Proteomics and Epigenomics Market Trends 2.2. Sample Preparation in Genomics, Proteomics and Epigenomics Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Sample Preparation in Genomics, Proteomics and Epigenomics Market Drivers 2.2.1.2. North America Sample Preparation in Genomics, Proteomics and Epigenomics Market Restraints 2.2.1.3. North America Sample Preparation in Genomics, Proteomics and Epigenomics Market Opportunities 2.2.1.4. North America Sample Preparation in Genomics, Proteomics and Epigenomics Market Challenges 2.2.2. Europe 2.2.2.1. Europe Sample Preparation in Genomics, Proteomics and Epigenomics Market Drivers 2.2.2.2. Europe Sample Preparation in Genomics, Proteomics and Epigenomics Market Restraints 2.2.2.3. Europe Sample Preparation in Genomics, Proteomics and Epigenomics Market Opportunities 2.2.2.4. Europe Sample Preparation in Genomics, Proteomics and Epigenomics Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Sample Preparation in Genomics, Proteomics and Epigenomics Market Drivers 2.2.3.2. Asia Pacific Sample Preparation in Genomics, Proteomics and Epigenomics Market Restraints 2.2.3.3. Asia Pacific Sample Preparation in Genomics, Proteomics and Epigenomics Market Opportunities 2.2.3.4. Asia Pacific Sample Preparation in Genomics, Proteomics and Epigenomics Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Sample Preparation in Genomics, Proteomics and Epigenomics Market Drivers 2.2.4.2. Middle East and Africa Sample Preparation in Genomics, Proteomics and Epigenomics Market Restraints 2.2.4.3. Middle East and Africa Sample Preparation in Genomics, Proteomics and Epigenomics Market Opportunities 2.2.4.4. Middle East and Africa Sample Preparation in Genomics, Proteomics and Epigenomics Market Challenges 2.2.5. South America 2.2.5.1. South America Sample Preparation in Genomics, Proteomics and Epigenomics Market Drivers 2.2.5.2. South America Sample Preparation in Genomics, Proteomics and Epigenomics Market Restraints 2.2.5.3. South America Sample Preparation in Genomics, Proteomics and Epigenomics Market Opportunities 2.2.5.4. South America Sample Preparation in Genomics, Proteomics and Epigenomics Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Sample Preparation in Genomics, Proteomics and Epigenomics Industry 2.8. Analysis of Government Schemes and Initiatives For Sample Preparation in Genomics, Proteomics and Epigenomics Industry 2.9. Sample Preparation in Genomics, Proteomics and Epigenomics Market Trade Analysis 2.10. The Global Pandemic Impact on Sample Preparation in Genomics, Proteomics and Epigenomics Market 3. Sample Preparation in Genomics, Proteomics and Epigenomics Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 3.1.1. Genomics 3.1.2. Proteomics 3.1.3. Epigenomics 3.1.4. Other Application 3.2. Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 3.2.1. Pharmaceutical 3.2.2. Biotechnology 3.2.3. Molecular Diagnostics 3.2.4. Others End User 3.3. Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Region (2022-2029) 3.3.1. North America 3.3.2. Europe 3.3.3. Asia Pacific 3.3.4. Middle East and Africa 3.3.5. South America 4. North America Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 4.1.1. Genomics 4.1.2. Proteomics 4.1.3. Epigenomics 4.1.4. Other Application 4.2. North America Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 4.2.1. Pharmaceutical 4.2.2. Biotechnology 4.2.3. Molecular Diagnostics 4.2.4. Others End User 4.3. North America Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Country (2022-2029) 4.3.1. United States 4.3.1.1. United States Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 4.3.1.1.1. Genomics 4.3.1.1.2. Proteomics 4.3.1.1.3. Epigenomics 4.3.1.1.4. Other Application 4.3.1.2. United States Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 4.3.1.2.1. Pharmaceutical 4.3.1.2.2. Biotechnology 4.3.1.2.3. Molecular Diagnostics 4.3.1.2.4. Others End User 4.3.2. Canada 4.3.2.1. Canada Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 4.3.2.1.1. Genomics 4.3.2.1.2. Proteomics 4.3.2.1.3. Epigenomics 4.3.2.1.4. Other Application 4.3.2.2. Canada Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 4.3.2.2.1. Pharmaceutical 4.3.2.2.2. Biotechnology 4.3.2.2.3. Molecular Diagnostics 4.3.2.2.4. Others End User 4.3.3. Mexico 4.3.3.1. Mexico Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 4.3.3.1.1. Genomics 4.3.3.1.2. Proteomics 4.3.3.1.3. Epigenomics 4.3.3.1.4. Other Application 4.3.3.2. Mexico Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 4.3.3.2.1. Pharmaceutical 4.3.3.2.2. Biotechnology 4.3.3.2.3. Molecular Diagnostics 4.3.3.2.4. Others End User 5. Europe Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 5.2. Europe Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 5.3. Europe Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Country (2022-2029) 5.3.1. United Kingdom 5.3.1.1. United Kingdom Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 5.3.1.2. United Kingdom Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 5.3.2. France 5.3.2.1. France Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 5.3.2.2. France Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 5.3.3. Germany 5.3.3.1. Germany Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 5.3.3.2. Germany Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 5.3.4. Italy 5.3.4.1. Italy Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 5.3.4.2. Italy Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 5.3.5. Spain 5.3.5.1. Spain Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 5.3.5.2. Spain Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 5.3.6. Sweden 5.3.6.1. Sweden Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 5.3.6.2. Sweden Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 5.3.7. Austria 5.3.7.1. Austria Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 5.3.7.2. Austria Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 5.3.8. Rest of Europe 5.3.8.1. Rest of Europe Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 5.3.8.2. Rest of Europe Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 6. Asia Pacific Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 6.2. Asia Pacific Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 6.3. Asia Pacific Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Country (2022-2029) 6.3.1. China 6.3.1.1. China Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 6.3.1.2. China Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 6.3.2. S Korea 6.3.2.1. S Korea Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 6.3.2.2. S Korea Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 6.3.3. Japan 6.3.3.1. Japan Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 6.3.3.2. Japan Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 6.3.4. India 6.3.4.1. India Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 6.3.4.2. India Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 6.3.5. Australia 6.3.5.1. Australia Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 6.3.5.2. Australia Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 6.3.6. Indonesia 6.3.6.1. Indonesia Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 6.3.6.2. Indonesia Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 6.3.7. Malaysia 6.3.7.1. Malaysia Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 6.3.7.2. Malaysia Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 6.3.8. Vietnam 6.3.8.1. Vietnam Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 6.3.8.2. Vietnam Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 6.3.9. Taiwan 6.3.9.1. Taiwan Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 6.3.9.2. Taiwan Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 6.3.10. Rest of Asia Pacific 6.3.10.1. Rest of Asia Pacific Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 6.3.10.2. Rest of Asia Pacific Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 7. Middle East and Africa Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 7.2. Middle East and Africa Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 7.3. Middle East and Africa Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Country (2022-2029) 7.3.1. South Africa 7.3.1.1. South Africa Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 7.3.1.2. South Africa Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 7.3.2. GCC 7.3.2.1. GCC Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 7.3.2.2. GCC Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 7.3.3. Nigeria 7.3.3.1. Nigeria Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 7.3.3.2. Nigeria Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 7.3.4. Rest of ME&A 7.3.4.1. Rest of ME&A Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 7.3.4.2. Rest of ME&A Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 8. South America Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 8.2. South America Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 8.3. South America Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Country (2022-2029) 8.3.1. Brazil 8.3.1.1. Brazil Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 8.3.1.2. Brazil Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 8.3.2. Argentina 8.3.2.1. Argentina Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 8.3.2.2. Argentina Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 8.3.3. Rest Of South America 8.3.3.1. Rest Of South America Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by Application (2022-2029) 8.3.3.2. Rest Of South America Sample Preparation in Genomics, Proteomics and Epigenomics Market Size and Forecast, by End User (2022-2029) 9. Global Sample Preparation in Genomics, Proteomics and Epigenomics Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Sample Preparation in Genomics, Proteomics and Epigenomics Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Agilent Technologies 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Bio-Rad Laboratories 10.3. Biotage AB 10.4. Danaher Corporation 10.5. F Hoffman La Roche 10.6. Illumina Inc. 10.7. Merck KgaA 10.8. PerkinElmer Inc. 10.9. Qiagen N.V. 10.10. Thermo Fisher Scientific Inc. 10.11. Waters Corporation 11. Key Findings 12. Industry Recommendations 13. Sample Preparation in Genomics, Proteomics and Epigenomics Market: Research Methodology 14. Terms and Glossary